2022
DOI: 10.3389/fphar.2022.862584
|View full text |Cite
|
Sign up to set email alerts
|

Tilianin Reduces Apoptosis via the ERK/EGR1/BCL2L1 Pathway in Ischemia/Reperfusion-Induced Acute Kidney Injury Mice

Abstract: Background: Acute kidney injury (AKI) is a common syndrome impacting about 13.3 million patients per year. Tilianin has been reported to alleviate myocardial ischemia/reperfusion (I/R) injury, while its effect on AKI is unknown; thus, this study aimed to explore if tilianin protects I/R-induced AKI and the underlying mechanisms.Methods: The microarray dataset GSE52004 was downloaded from GEO DataSets (Gene Expression Omnibus). Differential expression analysis and gene-set enrichment analysis (GSEA) were perfor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
7
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 14 publications
(7 citation statements)
references
References 60 publications
0
7
0
Order By: Relevance
“…Our research discovered that Egr1 + PTC owned stronger communications with other cells in the microenvironment, serving as catalysts for cell proliferation and immune inhibition. Based on these finding we speculated that Egr1 + PTC might play a protective factor in AKI and EGR1 could be a potential therapeutic target for AKI [ 56 ]. Despite the encouraging potential of Egr1 + PTC in AKI, more research is needed to understand the precise mechanisms by which it functions.…”
Section: Discussionmentioning
confidence: 99%
“…Our research discovered that Egr1 + PTC owned stronger communications with other cells in the microenvironment, serving as catalysts for cell proliferation and immune inhibition. Based on these finding we speculated that Egr1 + PTC might play a protective factor in AKI and EGR1 could be a potential therapeutic target for AKI [ 56 ]. Despite the encouraging potential of Egr1 + PTC in AKI, more research is needed to understand the precise mechanisms by which it functions.…”
Section: Discussionmentioning
confidence: 99%
“…Activation of ERK1/2 mediates cardiac hypertrophy and dysfunction, and in addition to its anti-apoptotic effects in the myocardium ( 49 , 50 ). The ERK/EGR1 signaling pathway has a critical role in the process of apoptosis in multiple organs ( 39 , 51 , 52 ). Inhibition of ERK1/2 kinase expression downregulates EGR1 expression, thereby reducing myocardial ischemia-reperfusion induced apoptosis and autophagy ( 39 ).…”
Section: Discussionmentioning
confidence: 99%
“…In VaD, several dysregulated miRNAs have been linked to the pathological processes of inflammatory cascades, oxidative stress, neurotrophic deficiency, and neuronal apoptosis. Differentially-expressed miRNAs can be corrected using oligonucleotide-based miRNA mimics and antisense nucleotides ( 38 ). These small molecule compounds are of considerable interest due to their potential for regulating miRNA expression ( 39 ).…”
Section: Discussionmentioning
confidence: 99%
“…Tilianin may offer various useful functions for treating cardiovascular diseases. For example, tilianin maintains the function of OGD/R-damaged heart by inhibiting apoptotic and inflammatory reactions ( 34 ) and reduces apoptosis in ischemia-induced acute kidney injury by inhibiting ERK/EGR1/BCL2L1 pathways ( 38 ). We previously demonstrated the cardio- and neuro-protection of tilianin against ischemia via the p-CaMKII and ox-CaMKII signaling pathways ( 9 , 18 , 24 ).…”
Section: Discussionmentioning
confidence: 99%